Bailard Inc. Sells 10,564 Shares of UnitedHealth Group Incorporated $UNH

Bailard Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,909 shares of the healthcare conglomerate’s stock after selling 10,564 shares during the quarter. Bailard Inc.’s holdings in UnitedHealth Group were worth $22,068,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Anchor Capital Advisors LLC raised its stake in shares of UnitedHealth Group by 0.3% during the third quarter. Anchor Capital Advisors LLC now owns 25,212 shares of the healthcare conglomerate’s stock valued at $8,706,000 after acquiring an additional 85 shares during the last quarter. Avidian Wealth Enterprises LLC raised its position in UnitedHealth Group by 94.4% during the 3rd quarter. Avidian Wealth Enterprises LLC now owns 3,375 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 1,639 shares during the last quarter. Rakuten Investment Management Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $9,076,000. Cornerstone Wealth Group LLC increased its stake in shares of UnitedHealth Group by 59.8% in the third quarter. Cornerstone Wealth Group LLC now owns 3,742 shares of the healthcare conglomerate’s stock valued at $1,292,000 after buying an additional 1,401 shares during the period. Finally, Samalin Investment Counsel LLC lifted its stake in shares of UnitedHealth Group by 37.6% in the third quarter. Samalin Investment Counsel LLC now owns 5,618 shares of the healthcare conglomerate’s stock worth $1,940,000 after acquiring an additional 1,535 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH opened at $338.47 on Wednesday. The company has a market cap of $306.60 billion, a price-to-earnings ratio of 17.67, a PEG ratio of 2.00 and a beta of 0.42. The company’s fifty day moving average price is $330.76 and its two-hundred day moving average price is $322.56. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $7.15 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Wall Street Analyst Weigh In

Several research firms have issued reports on UNH. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. Piper Sandler cut their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. TD Cowen lifted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Leerink Partners set a $410.00 target price on UnitedHealth Group and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, Sanford C. Bernstein increased their price target on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $385.75.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.